Highlights Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
286.1 ^USD	-0.39%		-1.16%	-11.40%

May. 14	Transcript : Bio-Rad Laboratories, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:05 PM
May. 08	UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	May. 07	RE
Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline	May. 07	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 Revenue $610.8M, vs. Street Est of $620.1M	May. 07	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 EPS $2.29, vs. Street Est of $2.14	May. 07	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	Apr. 11	CI
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	Mar. 25	MT
Bio Rad Labs rises after posting upbeat fourth-quarter profit	Feb. 15	RE
Bio-Rad Laboratories Q4 Adjusted Earnings, Revenue Decline, Shares Rise After-Hours	Feb. 15	MT
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Posts Q4 Revenue $681.2M, vs. Street Est of $686.6M	Feb. 15	MT
Earnings Flash (BIO.B) BIO-RAD LABORATORIES Reports Q4 EPS $3.10, vs. Street Est of $2.87	Feb. 15	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
Slow start for Wall Street	Jan. 03
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	23-10-27	CI
Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending	23-10-26	RE
Bio-Rad Laboratories Q3 Non-GAAP Earnings, Sales Decline -- Shares Drop After Hours	23-10-26	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Posts Q3 EPS $2.33, vs. Street Est of $2.81	23-10-26	MT
Earnings Flash (BIO) BIO-RAD LABORATORIES Posts Q3 Revenue $632.1M, vs. Street Est of $691.7M	23-10-26	MT
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Bio-Rad Laboratories' Q2 Non-GAAP Earnings, Revenue Fall	23-08-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Rad Laboratories, Inc.

Equities

BIO

US0905722072

Highlights

Filters